Pharmaceutical

HitGen and SGC enter drug discovery partnership

HitGen and the Structural Genomics Consortium entered a collaboration to discover drugs based on a DNA-encoded library (DEL).

Sep 29, 2023 - 20:00
HitGen and SGC enter drug discovery partnership
HitGen and the Structural Genomics Consortium entered a collaboration to discover drugs based on a DNA-encoded library (DEL).
Read the original article

Tags:

Previous Article

Amicus receives FDA approval for Pompe disease therapy

Next Article

Deka Biosciences secures $20m to advance product pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Absci and Caltech receive grant to develop HIV therapeutic vaccine

Absci and Caltech receive grant to develop HIV therapeu...

Aug 12, 2023

FDA declines to approve Satsuma’s migraine treatment STS101

FDA declines to approve Satsuma’s migraine treatment ST...

Jan 19, 2024

Insights from ISPOR Europe 2023: Copenhagen

Insights from ISPOR Europe 2023: Copenhagen

Dec 14, 2023